Number of suitable clients: CDEC talked over the uncertainty in the number of patients with reasonably severe to severe hemophilia B in Canada suitable for etranacogene dezaparvovec. Scientific experts consulted by CADTH indicated that some patients who're classified as having moderate or reasonable ailment could have a extreme bleeding phenotype, … Read More